Skip to main content
. 2019 Aug 28;13:843. doi: 10.3389/fnins.2019.00843

FIGURE 3.

FIGURE 3

Acylcarnitine concentrations are decreased in the cerebrospinal fluid (CSF) but not plasma of type 2 diabetes (T2D) monkeys. (A,B) Total and short-chain acylcarnitine concentrations were significantly decreased in the plasma of T2D and IR monkeys, (C,D), however, medium- and long-chain acylcarnitines were not significantly different. (E–H) There were no differences in plasma acylcarnitine concentrations between groups.p < 0.05; one-way ANOVA with Tukey’s post hoc test. Values represent mean ± SEM.